The Impact of a Robust Supplemental Screening Program on False-Negative Rates: Time for New Benchmarks?
A robust SS program allows for the symptomatic FNR to fall below published national performance benchmarks from the Breast Cancer Surveillance Consortium. Most patients with symptomatic IC were at higher-than-average risk and underutilized SS MRI.
Authors
- Ashley Huppe (ORCID: https://orcid.org/0000-0002-5571-5682)
- Camron Smith (ORCID: https://orcid.org/0009-0009-0245-2047)
- Allison M. Aripoli (ORCID: https://orcid.org/0000-0002-7379-6025)
- Lauren Clark (ORCID: https://orcid.org/0000-0002-7833-0945)
- Onalisa Winblad (ORCID: https://orcid.org/0000-0003-3560-2813)
- Molly Hill
- Jessica Peterson
- Carissa Walter
Institutions
- The University of Kansas Health System (US)
Publication Details
- Journal
- Journal of Breast Imaging
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1093/jbi/wbaf076
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00